PharmaCyte Biotech Overview
PharmaCyte Biotech Discounted Cash Flow
DCF Analysis for PMCB.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.07
Current Fair Value
$2.07
↑ 155.4% Upside
Undervalued by 155.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison